BUDGET IMPACT OF DURVALUMAB FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE STAGE III NONSMALL CELL LUNG CANCER IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

被引：0
|
作者：
Meirelles, I [1 ]
Costa, N. [1 ]
Dias, C. [2 ]
Massaoka, M. [2 ]
Lopes, D. G. [2 ]
Jabase, L. [3 ]
机构：
[1] IQVIA Real World Insights, Sao Paulo, SP, Brazil
[2] AstraZeneca, Cotia, Brazil
[3] AstraZeneca, Cotia, SP, Brazil
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE386
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [31] Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration
    Moore, Amanda M.
    Nooruddin, Zohra
    Reveles, Kelly R.
    Koeller, Jim M.
    Whitehead, Jennifer M.
    Franklin, Kathleen
    Datta, Paromita
    Alkadimi, Munaf
    Brannman, Lance
    Cotarla, Ion
    Frankart, Andrew J.
    Mulrooney, Tiernan
    Jones, Xavier
    Frei, Christopher R.
    ONCOLOGIST, 2023, 28 (09): : 804 - 811
  • [32] Real-Life Study of Patients with Unresectable Stage III Non-Small Cell Lung Cancer Treated with Chemoradiotherapy Followed by Durvalumab
    Tuller, M.
    Buela, G.
    Ferreira, Y.
    Antivero, A.
    Lupinacci, L.
    Basbus, L.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S607 - S608
  • [33] The Impact of Hospice Services in the Care of Patients with Advanced Stage Nonsmall Cell Lung Cancer
    Duggan, Kristy T.
    Duffus, Sara Hildebrand
    D'Agostino, Ralph B., Jr.
    Petty, William J.
    Streer, Nathan P.
    Stephenson, Richard C.
    JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (01) : 29 - 34
  • [34] Induction Immunochemotherapy Before Definitive Chemoradiotherapy for Patients with Stage III NonSmall Cell Lung Cancer
    Zheng, S.
    Sun, C.
    Zhang, H.
    Dong, B.
    Hou, Z.
    Chen, M.
    Li, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S583 - S583
  • [35] Treatment outcome of patients with unresectable stage III non-small cell lung cancer and interstitial pneumonia
    Ogawa, Kazumasa
    Takahashi, Yui
    Murase, Kyoko
    Hanada, Shigeo
    Uruga, Hironori
    Takaya, Hisashi
    Miyamoto, Atsushi
    Morokawa, Nasa
    Kurosaki, Atsuko
    Kishi, Kazuma
    RESPIRATORY INVESTIGATION, 2019, 57 (04) : 388 - 394
  • [36] OUTCOMES AND HEALTH-RELATED COSTS OF PATIENTS WITH UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Dias, C.
    Duarte, F. A.
    Santos, A.
    Massaoka, M.
    Denapoli, P. M. A.
    Lopes, D. G.
    Santana, P.
    Jabase, L.
    VALUE IN HEALTH, 2023, 26 (12) : S39 - S39
  • [37] Radiation therapy for elderly patients with inoperable or unresectable nonsmall cell lung cancer
    Hayakawa, K
    Mitsuhashi, N
    Katano, S
    Saito, Y
    Nakayama, Y
    Sakurai, H
    RADIOLOGY, 1999, 213P : 456 - 456
  • [38] The Efficacy of Durvalumab after Concurrent Chemoradiotherapy for EGFR-Mutated Stage III NonSmall Cell Lung Cancer (NEJ063)
    Kida, G.
    Fujisaki, T.
    Miyauchi, E.
    Kikuchi, H.
    Hommura, F.
    Yokoo, K.
    Tanaka, H.
    Kikuchi, T.
    Jingu, D.
    Sugisaka, J.
    Watanabe, K.
    Yoshimura, N.
    Nakagawa, T.
    Nogawa, H.
    Sato, M.
    Nakazawa, K.
    Soda, S.
    Takigami, A.
    Arai, D.
    Masubuchi, K.
    Miura, Y.
    Miura, Y.
    Nagai, Y.
    Matsumoto, N.
    Oba, T.
    Namba, Y.
    Ashinuma, H.
    Saito, G.
    Kamimura, M.
    Takahashi, S.
    Isobe, K.
    Miyawaki, T.
    Nishiyama, K.
    Sakashita, H.
    Nozaki, K.
    Inomata, M.
    Umeda, Y.
    Tateishi, K.
    Tetsumoto, S.
    Tamiya, M.
    Tsubata, Y.
    Masuda, K.
    Matsumoto, N.
    Obata, H.
    Yamaji, Y.
    Harada, M.
    Ohnishi, H.
    Nakao, A.
    Morita, S.
    Maemondo, M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S182 - S183
  • [39] COAST: Durvalumab Alone or with Novel Agents for Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer
    Herbst, R.
    Barlesi, F.
    Paz-Ares, L.
    Raben, D.
    Aggarwal, C.
    Bothos, J.
    Samadani, R.
    He, P.
    Angra, N.
    Martinez, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S450 - S451
  • [40] The impact of dosimetric parameters on pneumonitis in patients with stage III non-small cell lung cancer during maintenance treatment with durvalumab after chemoradiotherapy
    Vrankar, M.
    But-Hadzic, J.
    Stanic, K.
    Ciric, E.
    Jelercic, S.
    Vodusek, A. L.
    ANNALS OF ONCOLOGY, 2021, 32 : S944 - S944
12345